Some researchers believe that CD34 cannot make a distinction between the host’s primary blood vessels and the neo-angiogenesis; nonetheless, this marker is widely employed in appraising the vascular density in tumoral lesions.[20, 29]. This evidence concerns the gene CD34 and neoplasm.